Skip to content

Bio World 30 November 2021

Artrya lists on ASX in AU$40M IPO to advance coronary artery disease AI software

Medtech newcomer Artrya Ltd. listed on the Australian Securities Exchange (ASX) in an AU$40 million (US$28.6 million) initial public offering to commercialize its software that analyzes heart computed tomography (CT) scans via artificial intelligence (AI) to better diagnose coronary artery disease.